Rhaeos

Developer of a noninvasive device to monitor CSF and manage hydrocephalus. It offers a wireless non-invasive thermal flow sensor that is placed over the neck to monitor the ventricular shunt function and detect or measure CSF. Its data is transferred to an app to manage hydrocephalus. Founded in 2018, headquartered in Evanston, United States. The company has raised $12.8M in funding at the series a stage. The team comprises 19 (Jun 30, 2026) employees. The company operates in the Disease Self Management sector with additional focus on Sensors and Neurology. Its business model centers on Neural. Founded in 2018, headquartered in Evanston, United States. The company has raised $12.8M at the Series A stage. Backed by investors including Creative Ventures, Portal Innovations, Lateral Capital, Cedars-Sinai Accelerator, Kyto Technology & Life Science and others.

Wearable Technology > Health and Wellness Devices > Neural,

Disease Self Management > Neurological Disorders > Monitoring > Cognitive Abilities > App,

Healthcare IT > Provider > Clinical Operations > Decision Support > Diagnosis > Differential Diagnosis > Diagnostics > Devices and platform > Neurology,

Neurology > Medical Devices > Screening Devices > CSF and ICP Measurement,

Sensors > Generic Sensor Developers > Thermal Sensor